Chemical Structure (Cambia Figure 1)
Cambia Powder, For Solution
Product Images NDC 13913-012
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Cambia (NDC 13913-012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Assertio Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Graph (Cambia Figure 2)
Not-Available*
Cambia 50 mg Individual Packet (Cambia Figure 3)
CANBIA is a diclofenac potassium oral solution with a dosage of 50 mg. The packet can be opened easily by tearing along the dotted line, and stored at a temperature of 25°C. However, it may be stored within 15-30°C. The product information should be consulted before use. CANBIA is manufactured by Milan, Italy based company MiPham and is licensed under APR Applied Pharma Research SA, Balema, Switzerland.*
Cambia 50 mg Box Of 9 Packets (Cambia Figure 4)
This is a set of instructions for using a product called "Lorios 0 0" which requires a user to detach a single dose packet from the set and empty the contents into 1-2 ounces of water. Other liquids or foods are not recommended for use. Stir well and drink immediately. Children should be kept away from empty packets. The product may contain Potassium Bicarbonate and Sucrose, and is manufactured by WiPtam S Wien ey. This text is readable.*
Cambia Figure 5
This is a package of Diclofenac Potassium for oral solution, with each packet containing 50mg of the active ingredient. The medication is to be dispensed with an accompanying medication guide and should be kept out of reach of children. The directions for use state that the packet should be opened by holding the notch and tearing along the line. The contents should be dissolved in water before consuming. However, some parts of the text are not available due to poor quality.*
Cambia Figure 6
This is a medication called Cambia, containing the active ingredient Diclofenac Potassium in the strength of 50 mg. It is an oral solution used to relieve migraine pain. It comes in the form of a single-use oral packet, and it is only available with a prescription. The medication guide has to be dispensed with the packet of Cambia each time. The drug should be kept out of reach of children. The rest of the text is a mix of instructions, pharmaceutical information, and contact details, but not readable due to errors.*
Cambia Figure 7
This is a set of instructions for opening a packet of Diclofenac Potassium for Oral Solution. The instructions indicate that one should detach a single dose packet from the set of packets and fold on the dotted line to open it. It is also mentioned that scissors may be used as an aid. Dosage information, directions for use, and storage recommendations are also provided. The product is marketed by Depomed, Inc. and manufactured and distributed under license from APR Applied Pharma Research SA.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
